Zobrazeno 1 - 10
of 300
pro vyhledávání: '"G. Blackledge"'
Autor:
Julie A. Freischlag, Charles G. Blackledge, Peter J. Pronovost, Eugenie S. Heitmiller, Conan Dickson, Hanan Aboumatar
Publikováno v:
American Journal of Medical Quality. 22:232-238
The purpose of this article is to study morbidity and mortality conferences and their conformity to medical incident analysis models. Structured interviews with morbidity and mortality conference leaders of 12 (75%) clinical departments at Johns Hopk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1d90becf8779e32bac3d8e664357e95
https://doi.org/10.1177/1062860607303292
https://doi.org/10.1177/1062860607303292
Publikováno v:
Journal for Healthcare Quality. 28:27-31
To prevent adverse drug events for pediatric patients, increase care provider efficiency, and reduce stress for care providers, a technology tool was developed that calculates medication dosage requirements during emergency situations. This article d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdef8fab4ec70c3bb9aaf4627d945bea
https://doi.org/10.1111/j.1945-1474.2006.tb00599.x
https://doi.org/10.1111/j.1945-1474.2006.tb00599.x
Autor:
S Averbuch, G Blackledge
Publikováno v:
British Journal of Cancer
The epidermal growth factor receptor (EGFR) is a promising target for cancer therapy and a number of EGFR-targeted agents have been developed. Those most advanced in development are the EGFR tyrosine kinase inhibitors gefitinib ('Iressa', ZD1839) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c61c3df40d1c114228c423df09aa050f
http://europepmc.org/articles/PMC2409596
http://europepmc.org/articles/PMC2409596
Autor:
D. C. S. Gough, Yukio Kageyama, Hiroyuki Oshima, J.H.M. Blom, Kazunori Kihara, Gunnar Kratz, F. Algaba, A. Orsola, A. Webster, D. van den Ouden, J. Vicente, M.C. Michel, F. Wuyts, L. Baert, J. McEwen, J. Palou, T. O. Henkel, K. D’Hauwers, B. Xavier, Iwao Fukui, Andrea Haitel, T. Moreland, W. Oosterlinck, Christoph H. Klingler, A.H.V.C. de Spiegeleer, Christian Stock, Jean-Marie de Meyer, Thomas Zwergel, Aaltomaa Sirpa, T. Tammela, J. Salvador, Gertraud Heinz-Peer, Michael Marberger, J.B. Anderson, S. Sys, A.V. Kaisary, S. Buyle, Kieran J. O’Flynn, Yasuhisa Fujii, Volker Rohde, Thomas Frede, Ulrike Zwergel, C. Bangma, Bernd Wullich, Peter Alken, Toshihiko Tsujii, C.J. Tyrrell, Jens Rassweiler, Jan Eldh, Richard J. Brough, P. Iversen, C. de Mey, Carl-Johan Gustafson, Armin Pycha, Ala-Opas Martti, J.J. Wyndaele, Kazuhiro Ishizaka, M. Chamberlain, Janet Fishwick, Satoru Kawakami, G. Blackledge, Ulrike Lindenmeir
Publikováno v:
European Urology. 33:512-521
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10a3ff14f7af4ecf5092c167a2156903
https://doi.org/10.1159/000019647
https://doi.org/10.1159/000019647
Autor:
G Blackledge, John Anderson, M. Chamberlain, C.J. Tyrrell, Teuvo L.J. Tammela, Peter Iversen, Amir V. Kaisary, A Webster, L Baert
Publikováno v:
European Urology. 33:447-456
Objectives: To evaluate the efficacy and tolerability of ‘Casodex’TM monotherapy (150 mg daily) for metastatic and locally advanced prostate cancer. Methods: A total of 1,453 patients with either confirmed metastatic disease (M1), or T3/T4 non-me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93d3d529aa2c5e894c8a38ffec827f17
https://doi.org/10.1159/000019634
https://doi.org/10.1159/000019634
Autor:
G Blackledge
Publikováno v:
British Journal of Cancer
Following the demonstration of efficacy, tolerability and quality-of-life benefits of raltitrexed ('Tomudex'), principally in advanced colorectal but also in other cancers, an extensive evaluation of combination therapy with other agents in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33f00e4f5c9c200755f22b15cfd32c03
https://doi.org/10.1038/bjc.1998.423
https://doi.org/10.1038/bjc.1998.423
Autor:
G. Blackledge
Publikováno v:
Cancer. 72:3830-3833
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e49261246db21e1c1e53d52acc5391af
https://doi.org/10.1002/1097-0142(19931215)72:12+<3830::aid-cncr2820721713>3.0.co
https://doi.org/10.1002/1097-0142(19931215)72:12+<3830::aid-cncr2820721713>3.0.co
Autor:
G. Blackledge, F. Lawton
Publikováno v:
Current Obstetrics & Gynaecology. 1:170-175
Systemic therapy against gynaecological cancers is now firmly established. The majority of patients with gynaecological cancer will have disease which is inappropriate for cure with local therapy such as surgery or radiotherapy. Chemotherapy will inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7379577b647d1f0ad2dc8786bc8f36d1
https://doi.org/10.1016/0957-5847(91)90068-9
https://doi.org/10.1016/0957-5847(91)90068-9
Autor:
C.G.A. Price, A.Z.S. Rohatiner, T.A. Lister, W. Steward, D. Deakin, N. Bailey, A. Norton, G. Blackledge, D. Crowther
Publikováno v:
Annals of Oncology. 2:141-145
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52ee7b2acb3c0bee1dee62d7859411f3
https://doi.org/10.1093/annonc/2.suppl_2.141
https://doi.org/10.1093/annonc/2.suppl_2.141
Autor:
Cheryl R. Dennison, Charles G. Blackledge, Katherine Emery, Sean M. Berenholtz, Michael L. Rinke, Peter J. Pronovost
Publikováno v:
Journal of critical care. 19(3)
Purpose: Using sensitivity analysis to estimate the impact, in terms of patient lives, of the failure to use proven therapies known to reduce mortality in critically ill intensive care unit patients. Materials and Methods: We identified high-impact i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37c049b804c2f18b20a5ea710659a0f0
https://pubmed.ncbi.nlm.nih.gov/15484176
https://pubmed.ncbi.nlm.nih.gov/15484176